JAZZ
HOLD / NEUTRALMeanRevComposite
60.10
Technical
66.50
Fundamental
58.00
Rank
—
Price
243.82
Hurst
0.12
As of
Jul 13, 2026
Daily
Jazz Pharmaceuticals plc
HealthcareBiotechnologyJazz Pharmaceuticals plc is a biopharmaceutical company that researches, produces, and markets drugs globally, with operations centered in the United States and Europe. The company's marketed products treat neurological conditions including narcolepsy and epilepsy, as well as various cancers such as leukemia, lung cancer, and glioma. Its pipeline includes multiple investigational therapies in clinical development for oncology and neurological indications, supported by partnerships with several biotechnology and pharmaceutical firms.
Market cap
$15.8B
P/E (trailing)
16.68
P/E (forward)
9.46
PEG ratio
0.96
Dividend yield
—
Beta
0.36
52w range
125.79 – 266.38
Return on equity
+22.11%
Profit margin
+20.45%
Revenue growth
+15.50%
Earnings growth
—
Price history
1Y: 243.84 (+85.9%) · range 127.00–261.62
Cycle position
51/ 100 cycle scoreMID-BULL
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 22 · NOT READY · exit proximity 0
Conviction
34/ 100 · maturity 100%
VScore.4031
Buildup.2035
EMA entry setup.2522
Fundamentals.1558
Volume profile
POC
248.66
Price vs POC
-1.9%
Overhead supply
34%
Runway
+0.6%
Value area 224.19–257.94 · 34% of 120d volume overhead · moderate overhead
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| event-calendar | 0.499 | Sep 17, 2026 |
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | +8.25% | +10.40% | mature |
| 40d | +1.31% | +10.40% | mature |